RxSight (RXST) Change in Accured Expenses (2020 - 2026)
RxSight's (RXST) quarterly Change in Accured Expenses came in at -$1.3 million in Q1 2026, up 79.64% YoY from -$698632.9 in Q1 2025, and down 173.91% on a QoQ basis from $1.7 million in Q4 2025.
RxSight (RXST) Change in Accured Expenses (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Change in Accured Expenses data on file, last reported at -$1.3 million in Q1 2026.
- Quarterly Change in Accured Expenses rose 79.64% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (down 11.91% YoY) and the FY2025 annual result came in at -$1.9 million, down 131.95% from the prior year.
- Change in Accured Expenses eased to -$1.3 million in Q1 2026, from $1.7 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $3.7 million in Q3 2024 to a low of -$6.2 million in Q1 2025.
- A 5-year average of $580352.9 and a median of $1.6 million in 2025 frame the typical range for Change in Accured Expenses.
- The widest YoY moves for Change in Accured Expenses: up 91.9% in 2022, down 191.16% in 2022.
- Tracing RXST's Change in Accured Expenses over 5 years: stood at $2.4 million in 2022, then fell by 9.52% to $2.2 million in 2023, then soared by 58.72% to $3.5 million in 2024, then plunged by 51.26% to $1.7 million in 2025, then sank by 173.91% to -$1.3 million in 2026.
- The last three Change in Accured Expenses figures came in at -$1.3 million (Q1 2026), $1.7 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.80 Mn |
| 10 | RxSight | 250.81 Mn | -153.43 Mn | - | -262,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -262,000.00 |
| Jun 30, 2026 | -262,000.00 |
| Mar 31, 2026 | -1.26 Mn |
| Mar 31, 2026 | -1.26 Mn |
| Dec 31, 2025 | 1.70 Mn |
| Dec 31, 2025 | 1.70 Mn |
| Sep 30, 2025 | 1.56 Mn |
| Sep 30, 2025 | 1.56 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | -6.16 Mn |
| Mar 31, 2025 | -6.16 Mn |
| Dec 31, 2024 | 3.48 Mn |
| Dec 31, 2024 | 3.48 Mn |
| Sep 30, 2024 | 3.72 Mn |
| Sep 30, 2024 | 3.72 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Mar 31, 2024 | -3.74 Mn |
| Mar 31, 2024 | -3.74 Mn |